Navigation Links
Qualcraft™ Lightweight VestSkirt Apron

ProductsQualcraft™ Lightweight VestSkirt Apron
Company AliMed, Inc.
Item Qualcraft™ Lightweight VestSkirt Apron
Features 
  • More comfortable - divides weight between shoulders and hips, reducing fatigue during long-term wear Vest and Skirt generoulsy overlap in front for double protection. Vest front, 1.0 mm Pb equivalent with overlap (0.5 mm each flap); vest back, 0.25 mm Pb equivalent; skirt front, 0.5 mm Pb equivalent with overlap (0.25 mm each flap and skirt back)
  • Easy open and close Velcro-type fasteners
  • Skirt includes two 6" x 1" hanging loops and a pocket on the right side
  • Description Freedom of movement - plus full circle, maximum radiation protection. No other full circle radiation protection design approaches the level of comfort of the VestSkirt, which divides weight between the shoulders and hips.
    Info AliMed, Inc.
    Customer Service: (800) 225-2610
    Web site: http://www.alimed.com/

    Related medicine products :

    1. Qualcraft™ VestSkirt Apron, Standard
    2. Qualcraft™ Belted Coat Apron, Standard
    3. Qualcraft™ Back-Aid Apron
    4. Qualcraft™ Lightweight Tie Apron
    5. Qualcraft™ Belted Coat Apron, Lightweight
    6. Qualcraft™ Standard Tie Apron
    7. Qualcraft™ Lead-Free Back-Aid Radiation Protection Apron
    8. Fiberoptic Lightweight Coaxial Rotary Headlight
    9. Quick Drop Apron - Lightweight
    10. 511 Lightweight Pneumatic Conserver
    11. 511WG Lightweight Pneumatic Conserver
    Broncho-Cath® Endobronchial Tube with CPAP System
    ...made of silicone rubber with a wire reinforced end... of silicone rubber, Silbronco is soft and less tr...the tube will not soften like PVC tubes, which mak...lbronco is also especially useful when a tumor lif...
    Portex Pedia-Trake® Pediatric Emergency Cricothyrotomy Kit
    Melker Emergency Cricothyrotomy Catheter Sets
    Medicine Products:
    (Date:12/4/2009)WASHINGTON, Dec. 4 While Congress debates whether health care reform would control health care costs, Leapfrog,s purchaser members point to 45 hospitals that lead through example -- delivering the be
    (Date:12/4/2009)Late recurrence is a risk for some pediatric cancers, particularly Ewing sarcomas and tumors of the central nervous system, according to a new study published online December 4 in the Journal of the
    (Date:12/4/2009)Working with mice, scientists at Johns Hopkins publishing in the December issue of Neoplasia have shown that a protein made by a gene called "Twist" may be the proverbial red flag that can accuratel
    (Date:12/4/2009)More than 15 million Americans are recruited annually to participate in clinical trials according to the Alliance for Human Research Protection (AHRP), and most will be compensated for their participa
    (Date:12/4/2009)Dental tourism is a phenomenon that was started by people that were looking for an alternative to the high price of dental work in the US, Canada, and other countries. In their search for lower priced
    Breaking Medicine News(10 mins):Health News:The Leapfrog Group Releases Its 2009 Top Hospitals List 2Health News:The Leapfrog Group Releases Its 2009 Top Hospitals List 3Health News:Potential new 'twist' in breast cancer detection 2Health News:Potential new 'twist' in breast cancer detection 3Health News:Human guinea pigs wary of high-paying medical trials 2Health News:Mexican Dental Vacation Sees a Rush Of New Patients: Recession A Factor 2Health News:Mexican Dental Vacation Sees a Rush Of New Patients: Recession A Factor 3
    ...supplement no substitute for old-fashioned hard wo...ay News) -- Taking creatine doesn,t improve exerci... pulmonary disease (COPD), a U.K. study reports. ...eived either creatine or a placebo during a seven-...
    ... Mark Merritt, President,of the Pharmaceutical Ca...atement in response to new comparative effectivene... Finance Committee Chair Max Baucus,(D-Mont.) and ...ove quality through more objective,information and...
    ...ther treating the breathing disorder cuts the dang...althDay News) -- The interrupted nighttime breathi...dying, Australian researchers report. , Earlier st...s new study suggests that the risk is present amon...
    ...searchers at the University of Pennsylvania School... FOXA2 controls genes that maintain the proper lev...s for new therapies to treat diseases that involve...ll bladder and transported through ducts to the sm...
    ... Vertrue, for the second year in a row, is g...o families and children who need it the most. , ...1, 2008 -- For the second year in a row, http://w...ry of Vertrue, are giving away $1 million in disco...
    ... For the second consecutive year, Omega Inst...nebeck campus August 15-17, for professionals and ...plore the latest research and development in treat...host an important conference at its Rhinebeck camp...
    Other Medicine News:Health News:Creatine Has Negligible Effect on COPD Exercise Rehab 2Health News:Sleep Apnea Boosts Death Risk 2Health News:Sleep Apnea Boosts Death Risk 3Health News:Penn researchers find a new role for a 'Foxy Old Gene' 2Health News:Vertrue Incorporated and Feed The Children Join Forces to Give Away $1 Million in Aid to Families in Need 2Health News:Vertrue Incorporated and Feed The Children Join Forces to Give Away $1 Million in Aid to Families in Need 3Health News:Vertrue Incorporated and Feed The Children Join Forces to Give Away $1 Million in Aid to Families in Need 4Health News:Omega to Hold Conference: Autism Through the Life Span II 2Health News:Omega to Hold Conference: Autism Through the Life Span II 3
    (Date:12/3/2009)ALISO VIEJO, Calif. and STATE COLLEGE, Pa., Dec. 3 Ambry Genetics and SoftGenetics today announced the signing of an agreement to provide extended bioinformatics genomics services using SoftGenetics,
    (Date:12/3/2009)SAN DIEGO, Dec. 3 BioMed Realty Trust, Inc. (NYSE: BMR ) announced today that it has entered into a new lease with Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN ) for approximately 131,000 square
    (Date:12/3/2009)FORT WORTH, Texas, Dec. 3 Wound Management Technologies, Inc. (OTC Bulletin Board: WNDM), a rapidly growing provider of specialty medical products, announced today an agreement with the Health In
    Breaking Medicine Technology:Ambry Genetics and SoftGenetics Form Exclusive Alliance for Extended Bioinformatics Support for Next Generation Sequencing Projects 2Ambry Genetics and SoftGenetics Form Exclusive Alliance for Extended Bioinformatics Support for Next Generation Sequencing Projects 3BioMed Realty Trust Signs New Lease With Regeneron Pharmaceuticals for 131,000 Square Feet at Landmark 2BioMed Realty Trust Signs New Lease With Regeneron Pharmaceuticals for 131,000 Square Feet at Landmark 3Wound Management Technologies, Inc. Signs Agreement with Major Sales Representative Organization for Increased Marketing of CellerateRx(R); Third Quarter Sales Up 2Wound Management Technologies, Inc. Signs Agreement with Major Sales Representative Organization for Increased Marketing of CellerateRx(R); Third Quarter Sales Up 3Prime Retail Launches Operation Shop Pink 56749 1Prime Retail Launches Operation Shop Pink 56749 2Champions Biotechnology and PinnacleCare Enter Into Personalized Oncology Collaboration Agreement 13976 1Champions Biotechnology and PinnacleCare Enter Into Personalized Oncology Collaboration Agreement 13976 2Champions Biotechnology and PinnacleCare Enter Into Personalized Oncology Collaboration Agreement 13976 3Champions Biotechnology and PinnacleCare Enter Into Personalized Oncology Collaboration Agreement 13976 4Mpex Pharmaceuticals Announces Positive Phase 2b Clinical Trial Results with Aeroquin 28R 29 28MP 376 29 Treatment in Cystic Fibrosis Patients 13973 1Mpex Pharmaceuticals Announces Positive Phase 2b Clinical Trial Results with Aeroquin 28R 29 28MP 376 29 Treatment in Cystic Fibrosis Patients 13973 2Mpex Pharmaceuticals Announces Positive Phase 2b Clinical Trial Results with Aeroquin 28R 29 28MP 376 29 Treatment in Cystic Fibrosis Patients 13973 3Mpex Pharmaceuticals Announces Positive Phase 2b Clinical Trial Results with Aeroquin 28R 29 28MP 376 29 Treatment in Cystic Fibrosis Patients 13973 4